Statements (69)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:software
|
| gptkbp:academic_advisor |
eminent researchers
|
| gptkbp:analysis |
gptkb:machine_learning
|
| gptkbp:availability |
limited to certain regions
|
| gptkbp:awards |
recognized for innovation
|
| gptkbp:case_types |
multiple cancer types
|
| gptkbp:clinical_integration |
integrated into existing workflows
|
| gptkbp:clinical_trial |
ongoing
contributes to ongoing studies. |
| gptkbp:clinical_validation |
ongoing studies
|
| gptkbp:collaborations |
academic institutions
various healthcare institutions |
| gptkbp:collection |
real-time analytics
|
| gptkbp:community_feedback |
actively solicits input
|
| gptkbp:community_outreach |
educational initiatives
|
| gptkbp:competitors |
competes with other diagnostic tests
|
| gptkbp:customer_satisfaction |
high satisfaction rates
|
| gptkbp:data_privacy |
complies with HIPAA
ensures confidentiality of results |
| gptkbp:developed_by |
gptkb:Grail,_Inc.
|
| gptkbp:education |
available for healthcare providers
|
| gptkbp:eligibility |
asymptomatic individuals
|
| gptkbp:financial_support |
resources available
|
| gptkbp:funding |
gptkb:venture_capital
supported by grants |
| gptkbp:future_plans |
expand testing capabilities
|
| gptkbp:headquarters |
gptkb:Menlo_Park,_California
|
| gptkbp:healthcare |
increases access to testing
part of broader trends in diagnostics |
| https://www.w3.org/2000/01/rdf-schema#label |
Grail System
|
| gptkbp:innovation |
advances in cancer diagnostics
|
| gptkbp:is_tested_for |
blood test
ongoing improvements |
| gptkbp:is_visible_from |
committed to transparency in results
|
| gptkbp:launched_in |
gptkb:2020
|
| gptkbp:market_launch |
initially launched in the US
|
| gptkbp:marketed_as |
Galleri
|
| gptkbp:part_of |
precision medicine initiatives
Grail's multi-cancer early detection program |
| gptkbp:partnership |
collaborates with tech firms
|
| gptkbp:partnerships |
pharmaceutical companies
works with hospitals |
| gptkbp:patient_education |
provides informational resources
|
| gptkbp:performance |
high sensitivity
|
| gptkbp:price |
varies by provider
|
| gptkbp:provides_guidance_on |
integrated into some protocols
|
| gptkbp:publications |
peer-reviewed articles
|
| gptkbp:purpose |
early cancer detection
|
| gptkbp:regulatory_compliance |
FDA approval
meets industry standards |
| gptkbp:reporting_time |
short turnaround time
|
| gptkbp:research_focus |
cancer genomics
|
| gptkbp:security |
high-level encryption
|
| gptkbp:side_effect |
transformative potential
aims to reduce mortality rates improves early detection rates |
| gptkbp:treatment |
monitored for effectiveness
potentially improves survival rates |
| gptkbp:type |
gptkb:liquid
|
| gptkbp:type_of_care |
involves patients in decision-making
|
| gptkbp:user_base |
healthcare providers
|
| gptkbp:user_experience |
streamlined process
|
| gptkbp:user_feedback |
generally positive
|
| gptkbp:user_interface |
designed for ease of use
|
| gptkbp:uses_technology |
genomic sequencing
|
| gptkbp:bfsParent |
gptkb:Saber_(Berserker)
gptkb:Berserker_(Fate/_Zero) gptkb:Archer_of_Black |
| gptkbp:bfsLayer |
6
|